China Universal Asset Management Co., Ltd. Bicycle Therapeutics PLC Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,138 shares of BCYC stock, worth $161,176. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,138

Previous 4,220 69.15%

Holding current value

$161,176

Previous $85,000 89.41%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$19.58 - $27.24 $57,134 - $79,486	2,918 Added 69.15%	7,138 $161,000
Q2 2024 Jul 19, 2024	SELL	$20.02 - $24.69 $52,832 - $65,156	-2,639 Reduced 38.47%	4,220 $85,000
Q1 2024 Apr 29, 2024	BUY	$16.75 - $26.1 $47,871 - $74,593	2,858 Added 71.43%	6,859 $171,000
Q4 2023 May 21, 2024	SELL	$13.29 - $22.2 $37,982 - $63,447	-2,858 Reduced 41.67%	4,001 $72,000
Q4 2023 Jan 23, 2024	BUY	$13.29 - $22.2 $44,149 - $73,748	3,322 Added 489.25%	4,001 $72,000
Q3 2023 May 21, 2024	BUY	$19.9 - $26.25 $6,765 - $8,925	340 Added 100.29%	679 $13,000
Q3 2023 Oct 30, 2023	BUY	$19.9 - $26.25 $6,765 - $8,925	340 Added 100.29%	679 $14,000
Q2 2023 May 21, 2024	SELL	$18.95 - $28.67 $189 - $286	-10 Reduced 2.87%	339 $8,000
Q2 2023 Jul 27, 2023	SELL	$18.95 - $28.67 $189 - $286	-10 Reduced 2.87%	339 $9,000
Q1 2023 May 21, 2024	BUY	$20.02 - $31.37 $1,801 - $2,823	90 Added 34.75%	349 $7,000
Q1 2023 Apr 27, 2023	BUY	$20.02 - $31.37 $1,801 - $2,823	90 Added 34.75%	349 $7,000
Q4 2022 May 21, 2024	SELL	$20.37 - $32.9 $134,442 - $217,140	-6,600 Reduced 96.22%	259 $7,000
Q4 2022 Jan 31, 2023	BUY	$20.37 - $32.9 $407 - $658	20 Added 8.37%	259 $8,000
Q3 2022 Oct 21, 2022	BUY	$17.49 - $28.44 $4,180 - $6,797	239 New	239 $6,000

Others Institutions Holding BCYC

# of Institutions

112

Shares Held

41.2M

Call Options Held

39.6K

Put Options Held

24.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $670M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Bicycle Therapeutics PLC Transaction History